[unable to retrieve full-text content]Moderna Inc.’s potential coronavirus vaccine will not be ready by the U.S. presidential election, the drug maker’s chief executive told the Financial Times on Wednesday. See also GM Sees EV Squeeze as Canada Swaps Subsidies for Deadlines